Search Browse Earnings

XBiotech Inc.

Nasdaq:XBIT

Pharmaceutical Preparations·AUSTIN, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

XBiotech Inc. — SlamSEC

Revenue

$4.0M

-78.2% YoY

FY 2023

Adj. EBITDA

-$35.8M

-891.9% margin

FY 2024

Net Income

-$24.6M

-612.4% margin

FY 2024

EPS (Diluted)

-$0.81

FY 2024

Stock Price

$2.36

+0.4%

2026-03-10

52W Range

$2.09 – $3.62

P/E Ratio

-2.9x

Market Cap

$72.0M

Cash

$200.0M

FY 2024

Total Debt

—

Net Cash

$200.0M

FY 2023

Enterprise Value

-$128.1M

Debt / EBITDA

5.6x

FY 2023

EV / EBITDA

3.6x

Employees

—